SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-002422
Filing Date
2019-08-05
Accepted
2019-08-05 14:18:15
Documents
43
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q proteo_10q-063019.htm 10-Q 310060
2 LETTER AGREEMENT proteo_ex1025.htm EX-10.25 7877
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER proteo_ex3101.htm EX-31.1 9939
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER proteo_ex3102.htm EX-31.2 10151
5 CERTIFICATION proteo_ex32.htm EX-32 5499
  Complete submission text file 0001683168-19-002422.txt   1475237

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pteo-20190630.xml EX-101.INS 169255
7 XBRL SCHEMA FILE pteo-20190630.xsd EX-101.SCH 16674
8 XBRL CALCULATION FILE pteo-20190630_cal.xml EX-101.CAL 32856
9 XBRL DEFINITION FILE pteo-20190630_def.xml EX-101.DEF 72779
10 XBRL LABEL FILE pteo-20190630_lab.xml EX-101.LAB 120125
11 XBRL PRESENTATION FILE pteo-20190630_pre.xml EX-101.PRE 109794
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 19998277
SIC: 2834 Pharmaceutical Preparations